| Synonyms: | |
| Status: | Approved (2021) |
| Entry Type: | Protein |
| Molecule Category: | UNKNOWN |
| ATC: | L04AD03 |
| UNII: | 2PN063X6B1 |
| InChI Key | BICRTLVBTLFLRD-JDCIFRKPSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C63H111N11O12 |
| Molecular Weight | 1214.65 |
| AlogP | None |
| Hydrogen Bond Acceptor | None |
| Hydrogen Bond Donor | None |
| Number of Rotational Bond | None |
| Polar Surface Area | None |
| Molecular species | None |
| Aromatic Rings | None |
| Heavy Atoms | None |
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform inhibitor | FDA |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Lupus Nephritis | 4 | D008181 | ClinicalTrials |
| Uveitis | 3 | D014605 | ClinicalTrials |
| Uveitis, Intermediate | 3 | D015867 | ClinicalTrials |
| Uveitis, Posterior | 3 | D015866 | ClinicalTrials |
| Panuveitis | 3 | D015864 | ClinicalTrials |
| Psoriasis | 3 | D011565 | ClinicalTrials |
| Uveitis, Anterior | 3 | D014606 | ClinicalTrials |
| Dry Eye Syndromes | 2 | D015352 | ClinicalTrials |
| Kidney Diseases | 2 | D007674 | ClinicalTrials |
| Glomerulosclerosis, Focal Segmental | 2 | D005923 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 515814-01-4 |
| ChEMBL | CHEMBL2218919 |
| FDA SRS | 2PN063X6B1 |
| PubChem | 6918486 |